We are monitoring the impact of COVID-19 on APAC Sleep Aids Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1709
Share on
Share on

Asia-pacific Sleep Aids Market Research Report – Segmented By Sleep Disorder, Product, Medication & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1709
Pages: 136

APAC Sleep Aids Market Size (2021 to 2026)

The size of the Asia-Pacific Sleep Aids Market was worth USD 11.95 billion in 2021 and is estimated to be growing at a CAGR of 6.9%, to reach USD 16.68 billion by 2026.

The market is expected to show evident potential in the mentioned forecast period. The market is growing due to the rising geriatric population and increasing awareness among various organizations about sleep disorders. With the increase in the number of professionals working night shifts and rescheduling their sleeping time, sleeping aids will likely gain traction in the coming few years.

Sleep Aids are drugs or medical devices that help a person to fall asleep. Improper sleep cycles or sleep disorders have severe effects on one’s work life and health. Sleep Disorders are generally caused by changes in sleeping patterns due to medical issues, psychiatric problems, and environmental issues.

The increased usage of caffeine, tobacco, and alcohol has been causing sleep disorders in the population. This constitutes one of the major factors driving the Asia-Pacific sleep aids market. Further, an increase in demand for sleeping pills due to stressful modern lifestyle and awareness initiative for sleep disorder by various organizations has also contributed to the rapid growth of the Asia-Pacific Sleep Aids market. Apart from these, the sleep aids market also faces some challenges and restraints, including side effects associated with sleeping aids medications and patent expiration of treatment pills for sleep disorders.

This research report on the Asia Pacific Sleep Aids market has been segmented and sub-segmented into the following categories:

By Sleep Disorder:

  • Insomnia
  • Sleep Apnea
  • Restless legs syndrome
  • Narcolepsy
  • Sleepwalking

By Product:

  • Mattresses & Pillows
  • Sleep Laboratories
  • Medication
  • Sleep Apnea Devices

By Medication Type:

  • Prescription-based Drugs
  • OTC drugs
  • Herbal Drugs

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia-Pacific Sleep Aids market is segmented based on Sleep disorders, Products, and Medication types. Based on sleep disorder, the sleep aids market is segmented under Insomnia, Sleep Apnea, Narcolepsy, Restless legs syndrome, and Sleepwalking. The Asia-Pacific Sleep Aids market is segmented into Sleep Laboratories, Mattresses & Pillows, Medication, and Sleep apnea devices by product. Based on Medication types, the segmentation is done under Prescription-based Drugs, OTC drugs, and Herbal Drugs. Sleep apnea remains to be the fastest-growing segment compared to other sleep disorders. In contrast, Mattresses and pillows are expected to continue leading the Asia-Pacific Sleep Aids market in coming years. Based on medication type, prescription medications hold the largest share in the Sleep Aids market. Based on geographical analysis, the Asia-Pacific Sleep Aids market is segmented under various countries, namely China, India, Japan, Australia, and South Korea.

Some of the major companies dominating the Asia Pacific Sleep Aids market are Pfizer, Cadwell, Merck & Co., Koninklijke Philips N.V. (Philips), Sanofi, Care Fusion Corporation, GlaxoSmithKline Plc, Natus Medical manufactures, SleepMed, and DeVilbiss Healthcare LLC.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Sleep Disorder                                          

                                5.1.1 Introduction                           

                                5.1.2 Insomnia                  

                                5.1.3 Sleep Apnea                           

                                5.1.4 Restless legs syndrome                     

                                5.1.5 Narcolepsy                              

                                5.1.6 Sleep Walking                        

                                5.1.6  Y-o-Y Growth Analysis, By Sleep Disorder                 

                                5.1.7  Market Attractiveness Analysis, By Sleep Disorder                               

                                5.1.8  Market Share Analysis, By Sleep Disorder                                

                5.2 Product                                        

                                5.2.1 Introduction                           

                                5.2.2 Mattresses & Pillows                          

                                5.2.3 Sleep Laboratories                               

                                5.2.4 Medications                           

                                5.2.5 Sleep apnea devices                           

                                5.2.6 Y-o-Y Growth Analysis, By Product                               

                                5.2.7 Market Attractiveness Analysis, By Product                             

                                5.2.8 Market Share Analysis, By Product                               

                5.3 Medication                                 

                                5.3.1 Introduction                           

                                5.3.2 Prescription-based Drugs                 

                                5.3.3 OTC Drugs                               

                                5.3.4 Herbal Drugs                          

                                5.3.5 Y-o-Y Growth Analysis, By Medication                        

                                5.3.6  Market Attractiveness Analysis, By Medication                     

                                5.3.7  Market Share Analysis, By Medication                       

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Sleep Disorder             

                                                6.1.3.3 By Product           

                                                6.1.3.4 By Medication    

                                                6.1.3.5 By Indication       

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Sleep Disorder             

                                                6.1.4.3 By Product           

                                                6.1.4.4 By Medication    

                                                6.1.4.5 By Indication       

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Sleep Disorder             

                                                6.1.5.3 By Product           

                                                6.1.5.4 By Medication    

                                                6.1.5.5 By Indication       

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Sanofi                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Merck & Co                                

                8.3 Pfizer                                            

                8.4 Koninklijke Philips N.V.                                          

                8.5 GlaxoSmithKline Plc                                

                8.6 Care Fusion Corporation                                       

                8.7 Cadwell                                        

                8.8 Sleepmed                                   

                8.9 Natus Medical Manufacturers                                            

                8.10 DeVilbiss Healthcare LLC                                     

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  2. Asia-Pacific Insomnia Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia-Pacific Sleep Apnea Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia-Pacific Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Billion)
  5. Asia-Pacific Narcolepsy  Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia-Pacific Sleep Walking Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia-Pacific Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  8. Asia-Pacific Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia-Pacific Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia-Pacific Medication Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia-Pacific Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia-Pacific Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)
  13. Asia-Pacific Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia-Pacific OTC drugs Market, By Region, From 2021 to 2026 (USD Billion)
  15. Asia-Pacific Herbal Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  16. Japan Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  17. Japan Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  18. Japan Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)
  19. China Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  20. China Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  21. China Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)
  22. India Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  23. India Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  24. India Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)
  25. Australia Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  26. Australia Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  27. Australia Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)
  28. South Korea Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Billion)
  29. South Korea Sleep Aids Market, By Product, From 2021 to 2026 (USD Billion)
  30. South Korea Sleep Aids Market, By Medication, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample